Mr. Marek previously served as Chief Commercial Officer of Axsome Therapeutics. Prior to joining Axsome, Mr. Marek served as Vice President and General Manager of Amgen’s Neuroscience business unit where he led the U.S. commercialization strategy and launch of Aimovig® (erenumab-aooe) for migraine prevention. Mr. Marek also previously served as Executive Vice President, Consumer Services, and Commercial Strategy Officer of WebMD, and as Managing Director of Saatchi & Saatchi Healthcare Advertising. Mr. Marek began his career at Eli Lilly and Company, followed by AstraZeneca, where he served in a variety of marketing and sales roles. Mr. Marek earned a BA in business administration from Washington State University.